Clinical trial
Darbepoetin in Neonatal Encephalopathy (EDEN) Trial
NCT04432662 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Darbepoetin in Neonatal Encephalopathy (EDEN) Trial
- Lead sponsor
- Imperial College London
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- May 28, 2021
- Completion date
- September 1, 2024
- Enrollment
- 150 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
neonatal encephalopathy